Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia and flagella associated protein 221 (CFAP221) is a structural, non-enzymatic protein important for the assembly and proper function of motile cilia and flagella. It plays a key role as part of the central pair apparatus (CPA) within the axoneme, helping regulate ciliary beat frequency and motility. Variants in the CFAP221 gene can cause primary ciliary dyskinesia (PCD), a rare, inherited disorder characterized by chronic respiratory tract infections due to impaired mucociliary clearance, and can contribute to male infertility (in model organisms) by disrupting sperm flagellum assembly. The protein is involved in calmodulin binding and cilium morphogenesis but does not have any well-established role as a receptor, enzyme, or direct drug target. Its function is conserved in various species, indicating an essential role in motile ciliopathies and related disorders[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia and flagella associated protein 221 (CFAP221).